"Increasing transparency around PBMs will help improve the prescription drug pricing system, ensuring that patients are able to access and afford the drugs that they need.”
"There’s concerns, valid concerns, that consolidation in this industry might disincentivize competition, it could lead to higher prices for our patients or less access to important medications.”